Zydus to sell two brands to PE firm True North's portfolio company
Both drugs, Mifegest Cytolog are used for medical termination of pregnancy
 "Zydus to sell two brands to PE firm True North's portfolio company")
premium
Cadila Healthcare Limited (Zydus Cadila)'s wholly-owned subsidiary Zydus Healthcare Ltd is set to sell two of its brands to one of the portfolio companies of private equity (PE) major True North.
The company informed stock exchanges on Monday that Zydus Healthcare Limited has entered into an agreement with Integrace Private Limited to sell its brands Mifegest and Cytolog.
While Mifegest is an anti-progestational steroid class of drug used for medical termination of pregnancy, cytolog too is used for medical abortion apart from preventing excessive bleeding after delivery.
"The said transaction is expected to be completed within 30 days from the date of execution of agreement subject to customary approvals," the company informed stock exchanges in a filing on Monday.
Part of the portfolio companies of PE firm True North, Integrace's buyout of the two brands is not a related party transaction, Cadila stated.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%